Metandienone

DB13586ApprovedWithdrawnSmall molecule

Metandienone is an anabolic steroid indicated for appetite stimulation in patients with anorexia. It was introduced to the market in the 1960s but later discontinued and withdrawn from the market.

Mechanism: Pharmacologically active on Androgen receptor
Curator reviewed
Formula / weight: C₂₀H₂₈O₂ · 300.4351 g/mol (avg)
Also known as: Methandrostenolone
Code names: NSC-42722

Resolves to

Compound

UNIICOZ1R7EOCCCAS72-63-9ChEMBLCHEMBL1418176ChEBI6810

Clinical / RWD

RxNorm6818ATCA14AA03ATCD11AE01

Structure

InChIKeyXWALNWXLMVGSFR-HLXURNFRSA-NSMILES[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C

Targets

P10275AR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Structured indicationCondition, population, route and combination as fields, not prose

25Marketed productsAcross 2 countries and 6 labellers

2ATC codesIncluding every combination product, plus 14 drug categories

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Metandienone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account